Aug 2023 | Aug 2022 | ||
---|---|---|---|
Total Revenue | |||
Cost of Revenue | |||
Gross Profit | |||
Gross Profit Margin (%) | |||
R&D Expense | |||
SG&A Expense | |||
Total Operating Expenses | |||
Operating Income or Loss | |||
Operating Margin (%) | |||
Interest Expense | |||
Total Other Income/Expenses | |||
Income Before Tax | |||
Income Tax Expense | |||
Income from Continuing Ops. | |||
Net Income | |||
Net Profit Margin (%) | |||
Net Income Available to Common Shareholders | |||
Basic EPS | |||
Diluted EPS | |||
Basic Average Shares | |||
Diluted Average Shares |
Jun 2024 | Mar 2024 | Aug 2023 | May 2023 | Feb 2023 | Nov 2022 | Aug 2022 | May 2022 | Feb 2022 | Nov 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Total Revenue | |||||||||||
Cost of Revenue | |||||||||||
Gross Profit | |||||||||||
Gross Profit Margin (%) | |||||||||||
R&D Expense | |||||||||||
SG&A Expense | |||||||||||
Total Operating Expenses | |||||||||||
Operating Income or Loss | |||||||||||
Operating Margin (%) | |||||||||||
Interest Expense | |||||||||||
Total Other Income/Expenses | |||||||||||
Income Before Tax | |||||||||||
Income Tax Expense | |||||||||||
Income from Continuing Ops. | |||||||||||
Net Income | |||||||||||
Net Profit Margin (%) | |||||||||||
Net Income Available to Common Shareholders | |||||||||||
Basic EPS | |||||||||||
Diluted EPS | |||||||||||
Basic Average Shares | |||||||||||
Diluted Average Shares |
Aug 2023 | Aug 2022 | ||
---|---|---|---|
Current Assets | |||
Cash & Cash Equivalents | |||
Marketable Securities | |||
Receivables | |||
Inventories | |||
Other Current Assets | |||
Total Current Assets | |||
Non-Current Assets | |||
Marketable Securities | |||
PPE Net | |||
Intangibles inc. Goodwill | |||
Other Non-Current Assets | |||
Total Non-Current Assets | |||
Total Assets | |||
Current Liabilities | |||
Accounts Payable | |||
Deferred Revenues | |||
Debt, Current | |||
Accrued Liabilities | |||
Other Current Liabilities | |||
Total Current Liabilities | |||
Non-Current Liabilities | |||
Deferred Revenues | |||
Debt, Non-Current | |||
Other Non-Current Liabilities | |||
Total Non-Current Liabilities | |||
Total Liabilities | |||
Shareholders' Equity | |||
Common Stock | |||
Additional Paid-In Capital | |||
Retained Earnings | |||
Other Shareholders' Equity | |||
Total Shareholders' Equity | |||
Total Liabilities & Shareholders' Equity |
Jun 2024 | Mar 2024 | Aug 2023 | May 2023 | Feb 2023 | Nov 2022 | Aug 2022 | May 2022 | Feb 2022 | Nov 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Current Assets | |||||||||||
Cash & Cash Equivalents | |||||||||||
Marketable Securities | |||||||||||
Receivables | |||||||||||
Inventories | |||||||||||
Other Current Assets | |||||||||||
Total Current Assets | |||||||||||
Non-Current Assets | |||||||||||
Marketable Securities | |||||||||||
PPE Net | |||||||||||
Intangibles inc. Goodwill | |||||||||||
Other Non-Current Assets | |||||||||||
Total Non-Current Assets | |||||||||||
Total Assets | |||||||||||
Current Liabilities | |||||||||||
Accounts Payable | |||||||||||
Deferred Revenues | |||||||||||
Debt, Current | |||||||||||
Accrued Liabilities | |||||||||||
Other Current Liabilities | |||||||||||
Total Current Liabilities | |||||||||||
Non-Current Liabilities | |||||||||||
Deferred Revenues | |||||||||||
Debt, Non-Current | |||||||||||
Other Non-Current Liabilities | |||||||||||
Total Non-Current Liabilities | |||||||||||
Total Liabilities | |||||||||||
Shareholders' Equity | |||||||||||
Common Stock | |||||||||||
Additional Paid-In Capital | |||||||||||
Retained Earnings | |||||||||||
Other Shareholders' Equity | |||||||||||
Total Shareholders' Equity | |||||||||||
Total Liabilities & Shareholders' Equity |
Aug 2023 | Aug 2022 | ||
---|---|---|---|
Cash Flows from Operating Activities | |||
Net Income | |||
Depreciation & Amortization | |||
Deferred Income Taxes | |||
Stock Based Compensation | |||
Accounts Receivable | |||
Inventory | |||
Accounts Payable | |||
Deferred Revenue | |||
Other Non-Cash | |||
Operating Cash Flow | |||
Cash Flows from Investing Activities | |||
PPE Investments | |||
Net Acquisitions | |||
Purchase of Investments | |||
Sale of Investments | |||
Other Investing Activity | |||
Investing Cash Flow | |||
Cash Flows from Financing Activities | |||
Debt Issued | |||
Proceeds from Debt Repayment | |||
Debt Repayment | |||
Proceeds from Sale of Equity | |||
Equity Repurchased | |||
Dividend Paid | |||
Other Financing Activity | |||
Financing Cash Flow | |||
Cash Position | |||
Beginning Cash Position | |||
End Cash Position | |||
Change in Cash | |||
Free Cash Flow | |||
Operating Cash Flow | |||
Capital Expenditure | |||
Free Cash Flow |
Jun 2024 | Mar 2024 | Aug 2023 | May 2023 | Feb 2023 | Nov 2022 | Aug 2022 | May 2022 | Feb 2022 | Nov 2021 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flows from Operating Activities | |||||||||||
Net Income | |||||||||||
Depreciation & Amortization | |||||||||||
Deferred Income Taxes | |||||||||||
Stock Based Compensation | |||||||||||
Accounts Receivable | |||||||||||
Inventory | |||||||||||
Accounts Payable | |||||||||||
Deferred Revenue | |||||||||||
Other Non-Cash | |||||||||||
Operating Cash Flow | |||||||||||
Cash Flows from Investing Activities | |||||||||||
PPE Investments | |||||||||||
Net Acquisitions | |||||||||||
Purchase of Investments | |||||||||||
Sale of Investments | |||||||||||
Other Investing Activity | |||||||||||
Investing Cash Flow | |||||||||||
Cash Flows from Financing Activities | |||||||||||
Debt Issued | |||||||||||
Proceeds from Debt Repayment | |||||||||||
Debt Repayment | |||||||||||
Proceeds from Sale of Equity | |||||||||||
Equity Repurchased | |||||||||||
Dividend Paid | |||||||||||
Other Financing Activity | |||||||||||
Financing Cash Flow | |||||||||||
Cash Position | |||||||||||
Beginning Cash Position | |||||||||||
End Cash Position | |||||||||||
Change in Cash | |||||||||||
Free Cash Flow | |||||||||||
Operating Cash Flow | |||||||||||
Capital Expenditure | |||||||||||
Free Cash Flow |